We do not prescribe compounded versions of semaglutide or tirzepatide
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Compounded semaglutide typically produces weight loss ranging from 5-15% of body weight in clinical settings, though individual results vary considerably
Furthermore, additional risk factors identified in some studies include female gender, younger age, lower preoperative body mass index (BMI), and specific types of surgery, such as RYGB and sleeve gastrectomy (SG) [7, 31, 38]
The reality is that obesity carries the same health risks for men and that effective treatments like semaglutide work extremely well in men
Many doctors who guide patients through switching from Tirzepatide to Retatrutide emphasize patience during this early phase